Could an essential mineral hold the key to treating an aggressive form of breast cancer?
Researchers are studying the role of copper in the spread of triple negative breast cancer, and whether reducing copper levels in the body could help prevent this, thanks to new funding from Breast Cancer […]
GenesisCare and Cambridge University Hospitals NHS Foundation Trust to form a first-of-its-kind national partnership delivering advanced cell therapies in blood cancers
The UK’s largest private oncology provider and world-leading teams at Addenbrooke’s Hospital will work together to provide access to innovation and expertise in advanced cell therapies for cancer care. GenesisCare, […]
New rare cancer drug approved for NHS Scotland, taken as a tablet at home
Sarcoma UK has welcomed a decision last week by NHS Scotland to fund pazopanib, an oral treatment for adults with certain subtypes of advanced soft tissue sarcoma, following a proposal […]
Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
Zelluna ASA (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, has announced that the first patient has […]
Get A-Head funds pioneering database to transform thyroid cancer treatment
A major new research project that could change the way thyroid cancer is treated around the world is being funded by the Get A‑Head Charitable Trust. The head and neck […]
New study shows focal therapy effectively treats prostate cancer, keeping patients cancer-free 10 years after treatment
A targeted and minimally invasive treatment for prostate cancer called focal therapy, which destroys only the cancerous part of the prostate, is effective in delivering long term outcomes for patients, […]
Shaping the future of genitourinary oncology – IUCS 2026 prepares to welcome global experts
The scientific committee of the International Urology Cancer Summit (IUCS) has announced preparations for the 2026 event have received an exceptional response from the global research community. This year, the […]
NHSBT funds and supports organisations driving trials to help stem cell transplant recipients
Stem cell transplantation is an increasingly important treatment for many patients with blood cancer. While they give a second chance of life to thousands of people a year in the […]
The Medicines and Healthcare products Regulatory Agency (MHRA) grants marketing authorisation to AKEEGA® (niraparib and abiraterone acetate) for adult patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer (mHSPC)
Johnson & Johnson (J&J) has announced that the MHRA has granted marketing authorisation for AKEEGA® (niraparib and abiraterone acetate dual-action pill), with prednisone or prednisolone, in combination with androgen deprivation […]
Immunotherapy shows promise in treating deadly brain tumours
A study led by a researcher based at King’s College London and McMaster University in Canada has revealed how CAR-T cell therapy, a treatment that engineers a patient’s own immune […]
